Identification of eight candidate target genes of the recurrent 3p12–p14 loss in cervical cancer by integrative genomic profiling

The pathogenetic role, including its target genes, of the recurrent 3p12–p14 loss in cervical cancer has remained unclear. To determine the onset of the event during carcinogenesis, we used microarray techniques and found that the loss was the most frequent 3p event, occurring in 61% of 92 invasive carcinomas, in only 2% of 43 high‐grade intraepithelial lesions (CIN2/3), and in 33% of 6 CIN3 lesions adjacent to invasive carcinomas, suggesting a role in acquisition of invasiveness or early during the invasive phase. We performed an integrative DNA copy number and expression analysis of 77 invasive carcinomas, where all genes within the recurrent region were included. We selected eight genes, THOC7, PSMD6, SLC25A26, TMF1, RYBP, SHQ1, EBLN2, and GBE1, which were highly down‐regulated in cases with loss, as confirmed at the protein level for RYBP and TMF1 by immunohistochemistry. The eight genes were subjected to network analysis based on the expression profiles, revealing interaction partners of proteins encoded by the genes that were coordinately regulated in tumours with loss. Several partners were shared among the eight genes, indicating crosstalk in their signalling. Gene ontology analysis showed enrichment of biological processes such as apoptosis, proliferation, and stress response in the network and suggested a relationship between down‐regulation of the eight genes and activation of tumourigenic pathways. Survival analysis showed prognostic impact of the eight‐gene signature that was confirmed in a validation cohort of 74 patients and was independent of clinical parameters. These results support the role of the eight candidate genes as targets of the 3p12–p14 loss in cervical cancer and suggest that the strong selection advantage of the loss during carcinogenesis might be caused by a synergetic effect of several tumourigenic processes controlled by these targets. Copyright © 2013 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

[1]  C. Meijer,et al.  Chromosomal profiles of high‐grade cervical intraepithelial neoplasia relate to duration of preceding high‐risk human papillomavirus infection , 2012, International journal of cancer.

[2]  Yong Cheng,et al.  Significance of E-cadherin, β-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma. , 2012, Human pathology.

[3]  C. Meijer,et al.  HPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia , 2012, BMC Cancer.

[4]  Guoping Zheng,et al.  E-Cadherin/β-Catenin Complex and the Epithelial Barrier , 2011, Journal of biomedicine & biotechnology.

[5]  S. Reddy,et al.  GRIM-1, a Novel Growth Suppressor, Inhibits rRNA Maturation by Suppressing Small Nucleolar RNAs , 2011, PloS one.

[6]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[7]  P. Deloukas,et al.  Signatures of mutation and selection in the cancer genome , 2010, Nature.

[8]  Javier Benítez,et al.  Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes , 2009, Breast Cancer Research.

[9]  Marit Holden,et al.  Gene Dosage, Expression, and Ontology Analysis Identifies Driver Genes in the Carcinogenesis and Chemoradioresistance of Cervical Cancer , 2009, PLoS genetics.

[10]  U. Nir,et al.  TMF/ARA160 downregulates proangiogenic genes and attenuates the progression of PC3 xenografts , 2009, International journal of cancer.

[11]  C. Meijer,et al.  Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas. , 2009, Cancer research.

[12]  J. Griffiths,et al.  Nuclear localization of the pre‐mRNA associating protein THOC7 depends upon its direct interaction with Fms tyrosine kinase interacting protein (FMIP) , 2009, FEBS letters.

[13]  Ian M. Donaldson,et al.  iRefIndex: A consolidated protein interaction database with provenance , 2008, BMC Bioinformatics.

[14]  E. Hovig,et al.  GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data , 2008, Genome Biology.

[15]  J. Roth,et al.  Tumor suppressor FUS1 signaling pathway. , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  A. Mes-Masson,et al.  Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes , 2008, Molecular carcinogenesis.

[17]  J. Berkhof,et al.  Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial , 2007, The Lancet.

[18]  Qi Liu,et al.  BMC Bioinformatics BioMed Central Methodology article Comparative evaluation of gene-set analysis methods , 2007 .

[19]  N. Coleman,et al.  Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis? , 2007, The Journal of pathology.

[20]  H. Grabsch,et al.  DNA Quality Assessment for Array CGH by Isothermal Whole Genome Amplification , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[21]  Qi Liu,et al.  Improving gene set analysis of microarray data by SAM-GS , 2007, BMC Bioinformatics.

[22]  Wessel N. van Wieringen,et al.  CGHcall: Calling aberrations for array CGH tumor profiles. , 2008 .

[23]  Calum MacAulay,et al.  Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines , 2007, International journal of cancer.

[24]  Heri Ramampiaro,et al.  GeneTools – application for functional annotation and statistical hypothesis testing , 2006, BMC Bioinformatics.

[25]  T. Stokke,et al.  Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer , 2006, BMC Genomics.

[26]  Trevor Hastie,et al.  Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers , 2006, PLoS medicine.

[27]  C. Meijer,et al.  HPV‐mediated cervical carcinogenesis: concepts and clinical implications , 2006, The Journal of pathology.

[28]  Emmanuel Barillot,et al.  Analysis of array CGH data: from signal ratio to gain and loss of DNA regions , 2004, Bioinform..

[29]  T. Stokke,et al.  Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix , 2004, International journal of cancer.

[30]  J. Satrústegui,et al.  Identification of a Novel Human Subfamily of Mitochondrial Carriers with Calcium-binding Domains* , 2004, Journal of Biological Chemistry.

[31]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[32]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[33]  S. Roychowdhury,et al.  Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients , 2003, Molecular pathology : MP.

[34]  D. Albertson,et al.  Chromosome aberrations in solid tumors , 2003, Nature Genetics.

[35]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[36]  J. Epstein,et al.  Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. , 2003, The Journal of urology.

[37]  J. Minna,et al.  Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers , 2002, Oncogene.

[38]  M. Peter,et al.  The Death Effector Domain-associated Factor Plays Distinct Regulatory Roles in the Nucleus and Cytoplasm* , 2001, The Journal of Biological Chemistry.

[39]  E. Schröck,et al.  Advanced‐stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q , 1997, Genes, chromosomes & cancer.

[40]  J. Minna,et al.  Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. , 1997, Cancer research.

[41]  I. Christensen,et al.  A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. , 1983, Cytometry.

[42]  D. McCance.  Pathological Society of Great Britain and Ireland , 1984 .

[43]  W. N.,et al.  THE PATHOLOGICAL SOCIETY OF GREAT BRITAIN AND IRELAND , 1906 .

[44]  S. Bhaumik,et al.  The 26S proteasome complex: an attractive target for cancer therapy. , 2012, Biochimica et biophysica acta.

[45]  I. Wistuba,et al.  Deletions of Chromosome 3 p Are Frequent and Early Events in the Pathogenesis of Uterine Cervical Carcinoma , 2006 .

[46]  S. Naylor,et al.  Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. , 1997, Advances in cancer research.

[47]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .